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In cell suspensions subjected to high-shear rotatory motion, hu-
man PMN (polymorphonuclear cells) adhered to E-selectin-ex-
pressing CHO (Chinese-hamster ovary) cells (CHO-E), and
formed homotypic aggregates when challenged by E-selectin–IgG
fusion protein, by a mechanism that involved β2 integrins. Both
heterotypic and homotypic PMN adhesion was accompanied by
tyrosine phosphorylation of a 110 kDa protein (P110). This event
was prevented by blocking anti-(β2 integrin) antibodies and by
inhibitors of Src-family kinases, suggesting that it was part of an
‘outside-in’ signalling that was initiated by integrin engagement.
Interestingly, Src-family kinase inhibitors prevented β2-integrin-
mediated (i) homotypic PMN adhesion triggered by E-selectin–
IgG, (ii) heterotypic CHO-E/PMN adhesion in mixed-cell suspen-
sions, and (iii) firm adhesion of PMN to CHO-E monolayers under
physiological flow. Similarly to PMN treated with Src-family
kinase inhibitors, PMN from hck−/−fgr−/− and hck−/−fgr−/−lyn−/−
mice showed significant impairment of β2-integrin-mediated
adhesion to CHO-E. Moreover, the expression of β2 integrin
activation epitopes at the sites of cell–cell contact in CHO-E/
PMN conjugates was abolished by Src-family kinase inhibitors.
One component of P110 was identified as the FAK (focal adhe-
sion kinase) Pyk2 (proline-rich tyrosine kinase 2), which was
phosphorylated in a β2 integrin- and Src-family-kinase-dependent
manner. Thus, Src-family kinases, and perhaps Pyk2, mediate a
signal necessary for β2 integrin function in PMN tethered by
E-selectin.
Key words: adhesion, β2 integrin, leucocyte recruitment, poly-
morphonuclear leucocyte, proline-rich tyrosine kinase 2 (Pyk2),
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INTRODUCTION
E-selectin, a member of the selectin family that is expressed on
inflamed endothelium, promotes the initial capture and rolling
of PMN (polymorphonuclear cells). As they roll, PMN integrate
signals from the activated endothelium that result in full activation,
ligand binding by leucocyte β2 integrins, and PMN arrest [1].
Numerous studies have indicated that ‘inside-out’ signalling,
following engagement of chemo-attractant receptors, stimulates
inactive integrins to adopt an active conformation capable of
ligand binding [2,3]. Once bound to their ligands, integrins deliver
‘outside-in’ signals that result in transduction of mechanical force
to the cytoskeleton and assembly of signalling complexes at the
site of cell adhesion. These post-ligand-binding events may co-
operate to induce full integrin function [4–6].
Previous work in our laboratory and others indicates that
selectin binding to PMN may, by itself, promote β2 integrin
adhesiveness. In a pioneering study, Lo et al. [7] found that
either E-selectin expressed on cytokine-treated endothelial cells or
immobilized recombinant E-selectin stimulates αMβ2 adhesive
function. In studies of PMN adhesion to interleukin-1β-activated
endothelial cells in suspension, Kuijpers et al. [8] found that,
after pharmacological inhibition or removal of platelet-activating
factor from endothelial cell membranes, E-selectin was the major
mediator of β2 integrin activation and subsequent adhesion of
PMN to endothelial cells. More recently, soluble recombinant
E-selectin was shown to stimulate PMN function, including β2
integrin adhesiveness [9,10]. Under conditions of physiological
flow, Simon et al. [11] showed that PMN tethering on E-selectin
promoted β2-integrin-mediated adhesion to ICAM-1 (inter-
cellular cell-adhesion molecule 1). More recently, the same
authors further elucidated the mechanisms by which E-selectin
initiates β2 integrin adhesiveness, showing that co-capping of
L-selectin and PSGL-1 (P-selectin glycoprotein ligand 1) by E-
selectin induces a high-avidity state of β2 integrins in PMN [12].
Studies of another member of the selectin family have revealed
that P-selectin promotes the adhesiveness of αMβ2 in suspension
[13] and in static conditions [14]. Our previous studies suggested
that the activity of Src-family tyrosine kinases downstream of β2-
integrin-dependent outside-in signalling was necessary for αMβ2
adhesive function triggered by P-selectin [15]. In the present
study, using pharmacological inhibitors in human cells and cells
isolated from mice genetically deficient in different members
of the Src family, we examined the role of Src-family tyrosine
kinases in promoting β2 integrin adhesiveness in PMN tethered
by E-selectin.
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cell expressing E-selectin; F-actin, filamentous actin; FAK, focal adhesion kinase; HBSS, Hanks balanced salt solution; HE, hydroethidine; ICAM-1,
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Our data demonstrate that these signalling molecules mediate
post-ligand-binding events, which are necessary to sustain full
integrin high affinity and high avidity at the sites of PMN adhesion
initiated by E-selectin.
MATERIALS AND METHODS
HE (hydroethidine) was purchased from Molecular Probes Europe
(Leiden, The Netherlands); BCECF-AM [2′,7′-bis-(2-carboxy-
ethyl)-5(6)-carboxyfluorescein-acetoxymethyl ester], was from
Alexis (San Diego, CA, U.S.A.). Hepes and EGTA were
from Sigma (St Louis, MO, U.S.A.). PFA (paraformaldehyde) was
purchased from Fluka (Milan, Italy). Dextran T500 and Ficoll–
Hypaque were from Pharmacia (Uppsala, Sweden) and Aldrich
(Milan, Italy) respectively. BCECF-AM and HE were dissolved
in DMSO at concentrations of 1 mg/ml and 8 mg/ml respect-
ively, stored at −20 ◦C and used within 4 weeks. The ECL® (en-
hanced chemiluminescence)-kit was from Amersham Biosciences
(Little Chalfont, Bucks., U.K.). Reagents for electrophoresis and
Western-blot analysis were pure grade. The kinase inhibitors PP1
{4-amino-5-(methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrim-
idine} was purchased from Alexis, PP2 {4-amino-5-(4-chloro-
phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine} and the inactive
analogue PP3 {4-amino-7-phenylpyrazol[3,4-d]pyrimidine}
were from Calbiochem (La Jolla, CA, U.S.A.). Recombinant
human E-selectin–IgG fusion protein was kindly provided by
Genetics Institute (Cambridge, MA, U.S.A.). Soluble E-selectin
was purified from lysates of E-selectin-expressing CHO (Chinese-
hamster ovary) cells by immunoaffinity chromatography using
the anti(E-selectin) antibody H18/7.
Antibodies
The following mAbs (monoclonal antibodies) were kindly pro-
vided: anti-(β2 integrin) antibody KIM127 [16], by Dr M. K.
Robinson (Exploratory Research Cell Tech Therapeutics, Slough,
U.K.); and 327C, by D. Staunton (ICOS Corporation, Bothell,
WA, U.S.A.) [17]. The anti-(P-selectin) antibody WAPS 12.2
[18], anti-(E-selectin) antibody H18/7 [19], anti-(αL integrin)
antibody TS1/22 [20] and anti-(β2 integrin) antibody IB4 [21]
were purified from mouse ascites or hybridoma cell super-
nantant using Protein G–Sepharose affinity chromatography. The
anti-(mouse β2 integrin) antibody, Game-46, was purchased from
Pharmingen (San Diego, CA, U.S.A.). The PY99 (anti-phos-
photyrosine) antibody and the anti-Pyk2 (protein-rich tyrosine
kinase 2) antibody (clone C-19) were from Santa Cruz Biotech-
nology (Santa Cruz, CA, U.S.A.). The anti-Pyk2 antibody
recognizes both human and mouse protein. The recombinant
horseradish-peroxidase-conjugated anti-phosphotyrosine mAb
RC20 was from Transduction Laboratories (Exeter, U.K.). The
anti-[phospho-Src-family (Tyr416)] mAb was from Cell Signaling
Technology (Beverly, MA, U.S.A.).
Mice
C57BL/6J mice were purchased from Charles River Laboratories
(Calco, Lecco, Italy). Generation of double (hck−/−fgr−/−) or triple
(hck−/−fgr−/−lyn−/−) mutant mice was as described previously
[22]. Animals were housed and cared for by the Animal Care
Unit at the Consorzio Mario Negri Sud and used according to
procedures approved by the Institutional Animal Care and Use
Committee.
Preparation of PMN and culture of CHO cells
All protocols were approved by the Institutional Review Board
at Consorzio Mario Negri Sud. Blood was collected from healthy
volunteers who had not taken any medications for at least
2 weeks. Nine parts of blood were anti-coagulated with one part
of 3.8% (w/v) trisodium citrate. Blood was centrifuged to remove
platelet-rich plasma. PMN were isolated by dextran sedimentation
followed by Ficoll–Hypaque gradient and hypotonic lysis of
erythrocytes, washed and resuspended in ice-cold Hepes/Tyrode
buffer [23]. For adhesion assays, PMN (5 × 107 PMN/ml) were
stained with 20 µg of the vital red fluorescent dye HE for 30 min
at 4 ◦C as described previously [23]. Immediately before use,
MgCl2 and CaCl2 were added to the suspension of PMN to
bring the concentration of both bivalent ions to 1 mM. All of the
procedures for PMN isolation were performed at 4 ◦C using sterile
materials.
Wild-type CHO cells or CHO cells stably transfected with the
cDNA encoding human E-selectin (CHO-E) were kindly provided
by Genetics Institute (Cambridge, MA, U.S.A.) and were cultured
as described previously [24]. CHO cells stably transfected with
mouse E-selectin were kindly provided by Dr D. Vestweber
(Institute of Cell Biology, Center for Molecular Biology of Inflam-
mation, University of Munster, Germany). For mixed-cell sus-
pension assays, CHO and CHO-E cells were grown to conflu-
ence and detached with 5 mM of both EGTA and EDTA, washed
twice in Hepes/Tyrode buffer, and resuspended in the same
buffer at a concentration of 107 cells/ml. For adhesion assay in
suspension, CHO and CHO-E cells were loaded with the green
fluorescent dye BCECF-AM. For flow assays, wild-type CHO
cells and CHO-E cells were cultured on tissue-culture glass slides
for 2–3 days and used at confluence.
Mouse bone marrow PMN were isolated from femurs and
tibias of five to ten wild-type or double (hck−/−fgr−/−) or triple
(hck−/−fgr−/−lyn−/−) mutant mice (18–25 g) for each experiment.
Briefly, bone marrow cells were flushed from the bones using
Ca2+- and Mg2+-free HBSS (Hanks balanced salt solution)
containing 0.1% (w/v) BSA. Cells were aspirated through an 18
gauge needle to disrupt clumps. After removal of contaminating
erythrocytes by lysis in 0.15 M NH4Cl, 1 mM KHCO3, and
0.1 mM sodium EDTA, the remaining bone marrow cells were
washed twice and resuspended in Ca2+- and Mg2+-free HBSS
containing 0.1% (w/v) BSA. PMN were then purified by
centrifugation on Ficoll–Hypaque gradient, as described above
for human cells. Final cellular suspensions contained 80% PMN
as determined by light microscopy.
Flow adhesion assay
PMN adhesion under physiological flow was investigated in a
parallel plate flow chamber. CHO or CHO-E cells were grown
to confluence on glass slides, the slides were washed and then
mounted in the chamber. PMN [(5 × 106)/ml] suspended in M199
medium (Bio-Whittaker Europe, Verviers, Belgium) contain-
ing 0.1% (w/v) BSA were perfused across the CHO cell surface
at a flow rate of 4 dyn/cm2 for 2 min. The chamber was then
perfused with fresh medium for 2 min at 10 dyn/cm2. The inter-
action of PMN with CHO cells was observed by phase contrast
video microscopy with a ×20 objective (Olympus, Germany).
Images were continuously recorded (Pro-Series video camera,
High Performance CCD camera, Media Cybernetics, Silver
Spring, MD, U.S.A.). The fractions of rolling and firmly adhered
PMN were quantified using ad hoc software for image analysis
(Image Pro-Plus for Windows, Media Cybernetics), in the last
20 s of flow. In some experiments, E-selectin on CHO-E was
blocked by treatment with the mAb H18/7 (20 µg/ml) for 15 min.
β2 Integrins were blocked by treating PMN with the mAb
IB4 (20 µg/ml) for 15 min in ice. The anti(P-selectin) antibody
WAPS 12.2 was used as an isotype-matched control material for
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both H18/7 and IB4. Where indicated, PMN were treated with
Src inhibitors, inactive analogue or DMSO for 5 min at room
temperature (23–24 ◦C).
Mixed-cell suspension assay
PMN alone, or mixed with CHO cells at a PMN/CHO ratio of
5:1, were incubated in a final volume of 500 µl in siliconized
glass tubes (internal diameter 6 mm; ChronoLog, Mascia Brunelli,
Milan, Italy). The tubes were placed in a PICA (platelet ion-
ized calcium aggregometer; ChronoLog) at 37 ◦C and stirred at
1000 rev./min using a 4 mm magnetic stirrer for different periods
of time (as indicated in the Figure legends). Although the shear
rate produced by this stirring speed cannot be quantified precisely,
it should be approx. 250 s−1 [25]. For blocking studies, antibodies
were incubated at saturating concentration (20 µg/ml) with the
desired cell fraction for 15 min at 4 ◦C. Protein kinase inhibitors
or the diluent (DMSO) were incubated with PMN for 2 min at
room temperature before mixing them with CHO cells or soluble
E-selectin.
The formation of PMN/CHO cell mixed conjugates was
quantified by double-colour flow-cytometric analysis as described
previously [13,15]. Briefly, BCECF-loaded CHO cells and HE-
loaded PMN were incubated together as described above. At
different times, an equal volume of 2% (w/v) PFA was added, and
the cells fixed for 30 min. After fixation, samples were analysed
by flow cytometry as follows. A gate was set on the CHO cells,
identified by their green fluorescence (FL1). In each experiment,
a sample of CHO cells mixed with PMN in the presence of 10 mM
EGTA was used to set the threshold for the red (PMN-specific)
fluorescence (FL2). The threshold was set such that 90% of events
(CHO) were below the threshold. The percentage of CHO cells in
each sample with red fluorescence above the threshold represented
the percentage of CHO cells which bound at least one PMN [CHO
(+)]. A semi-quantitative estimate of the number of PMN adhered
per single CHO (+) (i.e. those CHO cells with red fluorescence
above the threshold) was obtained as follows: the FL2 MFI (mean
fluorescence intensity) of the CHO (+) population was divided
by the FL2 MFI of the PMN population, before multiplying by
the percentage of positive CHO cells, to yield an estimate of the
number of PMN attached to 100 CHO cells (PMN per 100 CHO).
PMN homotypic aggregation
PMN aggregation can be considered as an index of the adhesive
function of integrins αLβ2 and αMβ2 [26,27]. To evaluate
the effect of soluble E-selectin on PMN aggregation, PMN
[(5 × 106)/ml] were stirred at 1000 rev./min at 37 ◦C for 3 min
with different amounts of E-selectin–IgG chimaera or purified
E-selectin. The reaction was stopped by the addition of an equal
volume of 2% (w/v) PFA and the number of non-aggregated PMN
(single PMN) was evaluated by light microscopy. These soluble
forms of E-selectin did not aggregate PFA-fixed PMN. Similar
results were obtained with either the recombinant E-selectin–IgG
chimaera or E-selectin that was purified from CHO-E.
Tyrosine phosphorylation experiments
PMN were stirred without or with CHO cells (5:1 PMN/CHO)
or E-selectin–IgG chimaera as described in the mixed-cell
suspension assay. The reaction was stopped at different times by
the addition of an equal volume of 2× reducing Laemmli’s buffer,
and protein tyrosine phosphorylation was analysed as described
previously [15]. Src kinase activity in the PMN lysates subjected
to SDS/PAGE (7.5 % gel) was detected by immunoblotting with
anti-[phospho-Src-family (Tyr416)] antibody.
Pyk2 immunoprecipitation and detection
PMN were pretreated with 5 mM iPr2P-F (di-isopropyl fluoro-
phosphate) in order to assure complete inhibition of intracellular
proteases. Samples of iPr2P-F-pretreated PMN (5 × 106 cells)
were incubated with or without 20 µg/ml E-selectin–IgG or mixed
with CHO-E (5:1 PMN/CHO-E) and then lysed in reducing
Laemmli’s buffer containing protease and phosphatase inhibi-
tors (2 mM sodium orthovanadate, 5 mM EGTA, 5 mM EDTA,
10 mM sodium pyrophosphate, 10 mM iodoacetic acid, 1 mM
PMSF, 10 mM sodium fluoride, 1 mg/ml trypsin–chymotrypsin
inhibitor, 10 µg/ml leupeptin and 10 µg/ml aprotinin), boiled for
10 min, and diluted 1:20 with 1% (v/v) Triton X-100 lysis buffer
[1% (v/v) Triton X-100, 150 mM NaCl and 25 mM Tris/HCl,
pH 7.4] containing protease and phosphatase inhibitors (as
above). After pre-clearing, immunoprecipitation was performed
by incubating the samples at 4 ◦C overnight with 10 µg/ml anti-
Pyk2 antibody and Protein G–Sepharose beads (45–165 µm,
Pharmacia). Beads were washed three times with 1% (v/v) Triton
X-100 lysis buffer, once with PBS, re-suspended with reducing
Laemmli’s buffer and analysed by SDS/PAGE (7.5 % gels).
Western blotting was performed with either 0.1 µg/ml anti-Pyk2
antibody or PY99 antibody followed by horseradish-peroxidase-
conjugated anti-(goat IgG) and anti-(mouse IgG) respectively.
The intensity of the signal was analysed using a digital imaging
analysis system (1D Image Analysis Software, Kodak, NY,
U.S.A.).
Measurement of ‘activated’ β2 integrins by flow cytometry
The percentage of activated β2 integrin was evaluated by
measuring the binding of the activation-dependent mAb KIM127
or 327C in parallel with the binding of the activation-independent
β2 integrin mAb IB4 as described by Lu et al. [28]. PMN, alone or
stimulated with soluble E-selectin for 2 min without stirring, were
incubated with 10 µg/ml KIM127 or IB4 for an additional 5 min
at 37 ◦C in the presence of 1 mM Ca2+ and 1 mM Mg2+ or 2 mM
Mn2+. The cells were fixed in 2% PFA, washed and stained with
Alexa Fluor®-488-conjugated goat anti-mouse antibody (Mol-
ecular Probes) at 4 ◦C for 30 min. Non-specific fluorescence
was determined by incubation of PMN with Alexa Fluor®-488-
conjugated goat anti-mouse antibody only and was subtracted
from the MFI obtained in the presence of either KIM127 or IB4.
The specific MFI for KIM127 was expressed as a percentage
of the specific MFI of IB4.
Confocal microscopy
The localization of activated integrins was investigated using the
mAbs KIM127 and 327C. After stirring at 1000 rev./min for
2 min, PMN (resting or activated with 20 µg/ml soluble E-
selectin–IgG fusion protein or mixed with CHO-E) were incu-
bated for an additional 5 min at 37 ◦C with 10 µg/ml KIM127 or
327C without stirring and then fixed overnight with 2% (w/v)
PFA. Samples were then incubated for 30 min at 4 ◦C with Alexa
Fluor®-488-conjugated goat anti-mouse antibody, permeabilized
with PBS containing 0.05% (w/v) saponin (Sigma–Aldrich) and
0.5% (w/v) BSA for 30 min at 4 ◦C, and F-actin (filamentous
actin) was stained with 1 µg/ml rhodamine–phalloidin (Sigma–
Aldrich) in PBS containing 0.01% (w/v) saponin and 0.5 % (w/v)
BSA for 30 min at 4 ◦C. Samples were re-suspended in Mowiol
(Calbiochem), plated on a glass cover-slip, and observed with a
Zeiss LSM 510 Laser Scanning Microscope equipped with Axio-
vert 100 M-BP (Carl Zeiss, Jena, Germany), objective ×60.
Optical Z-sections from each sample were taken with 0.3 µm Z-
step from the top to the bottom of the cell. Immunofluorescence
images were acquired at high confocality (pinhole = 1 Airy unit)
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to achieve the thinnest optical slices. Fluorescence intensity cor-
responding to the binding of KIM127 or 327C was measured
using the ‘Display-Profile’ option of LSM510 software (Carl
Zeiss). One line was traced along the diameter of the PMN, which
crossed the cell from side to side. The intensity of fluorescence was
measured along this line both at the adhesion and non-adhesion
sites and was expressed in arbitrary units (from 0 to 255).
RESULTS
Tethering by E-selectin triggers β2-integrin-dependent adhesion
and a β2-integrin-dependent outside-in signal resulting in tyrosine
phosphorylation of a 110 kDa protein, in human PMN
In initial experiments, we evaluated PMN adhesion to wild-type
CHO cells or CHO-E in mixed-cell suspensions (5:1 PMN/CHO).
When PMN were incubated with CHO-E for 2 min under stirring
conditions (see Materials and methods section), 60 +− 3.0%
(mean +− S.E.M., n = 5) of CHO-E bound one or more PMN. By
evaluating the relative number of PMN recruited by CHO-E (see
Materials and methods section), we found that 60 +− 3.0 CHO-E
bound 165 +− 35 PMN (mean 2.8 +− 0.5 PMN per CHO-E). The
formation of mixed PMN/CHO-E conjugates occurred rapidly,
reaching a maximum at 3 min, and remained stable up to 10 min
(Figure 1A). In contrast, only 17 +− 5.0% of wild-type CHO cells
interacted with PMN, and each CHO cell bound no more than one
PMN. The adhesion of CHO-E stirred with PMN in the presence
of 5 mM EGTA was similar to that of CHO cells (Figure 1A).
Thus expression of E-selectin is necessary for PMN adhesion to
CHO cells.
Pretreatment of PMN with the β2 integrin-function-blocking
mAb IB4 significantly reduced, but did not abolish, PMN binding
to CHO-E (Figure 1B), suggesting a role for β2 integrins. In
order to elucidate further the functional relevance of integrin–
ligand interactions, E-selectin interactions were allowed to oc-
cur for 2 min and were then reversed by the addition of 5 mM
EGTA for 30 s before fixation to disrupt the Ca2+-dependent,
selectin-mediated interactions. The presence of Mg2+ sustains
integrin-dependent binding in the absence of Ca2+. Under control
conditions, this brief EGTA treatment (stop EGTA, Figure 1B)
did not significantly modify the percentage of CHO-E with
bound PMN, indicating that once formed, the mixed-cell con-
jugates are sustained via a selectin-independent mechanism. Im-
portantly, in samples in which PMN were pretreated with IB4,
brief exposure to EGTA completely disrupted mixed-cell con-
jugates (Figure 1B). Thus β2 integrins mediate CHO-E–PMN
adhesion. In contrast, IB4 did not modify PMN interaction with
wild-type CHO cells, suggesting that the slight capability of these
cells to interact with PMN does not involve β2 integrins.
We next investigated the ability of soluble E-selectin to trig-
ger β2 integrin adhesiveness as assessed by the induction of
homotypic PMN aggregation. PMN stirred with E-selectin–IgG
fusion protein for 3 min formed homotypic aggregates that were
dependent on the concentration of E-selectin–IgG (Figure 2A).
The formation of homotypic aggregates was accompanied by
increased tyrosine phosphorylation of a protein with a molecular
mass of approx. 110 kDa (P110). Homotypic adhesion and protein
tyrosine phosphorylation were both abolished by the β2 integrin
mAb IB4 (Figure 2B), suggesting that β2 integrins mediate homo-
typic adhesion and trigger tyrosine phosphorylation.
Src kinase activity is required for β2-integrin-mediated outside-in
signalling and β2-integrin-dependent firm adhesion triggered by
E-selectin
Like β2 integrin blockade (Figure 2B), PP1 (a specific inhi-
bitor of Src-family kinases; [29]), but not PP3 (its inactive ana-
Figure 1 Adhesion of human PMN to CHO-E in stirred cell suspensions:
role of the β2 integrins
(A) HE-loaded PMN were incubated with BCECF-loaded wild-type CHO or E-selectin-expressing
CHO-E cells in the absence or presence of 5 mM EGTA at a PMN/CHO cells ratio of 5:1 (stirring
at 37◦C and 1000 rev./min). At different times the interaction was stopped by 1 vol. of 2 % (w/v)
PFA and mixed-cell conjugates were analysed by flow cytometry. The graph shows the percentage
of CHO cells that bound PMN [CHO (+)]. Values are means +− S.E.M. for four experiments.
Differences between groups were analysed by repeated measurement ANOVA. *P < 0.05
compared with CHO or CHO-E + EGTA groups. (B) HE-loaded PMN were pre-incubated
for 10 min at 4◦C with or without saturating concentrations of the anti-(β2-integrin) mAb,
IB4, and mixed by stirring for 2 min at 37◦C and 1000 rev./min with BCECF-loaded CHO-E.
The interaction was stopped by the addition of 1 vol. of 2 % (w/v) PFA (standard condition).
Alternatively, in order to disrupt the Ca2+-dependent selectin–ligand interaction, 5 mM EGTA
was added to mixed cells 30 s before addition of 2 % (w/v) PFA (stop EGTA). Samples were
then processed for FACS analysis of mixed-cell conjugates. The graph shows the percentage
of CHO cells that bound PMN [CHO (+)]. Values are means +− S.E.M. for three to five
experiments. Differences between groups were analysed by repeated measurement ANOVA.
*P < 0.05 compared with control group.
logue), dose-dependently inhibited homotypic PMN adhesion
(Figure 3A) as well as P110 tyrosine phosphorylation (Figure 3B)
triggered by soluble E-selectin–IgG chimaera. In order to prove
that Src-family kinases were activated during the formation of
PMN aggregates, lysates were immunoblotted with an antibody
recognizing phosphorylated Tyr416 of Src. Autophosphorylation
of Src Tyr416 can be used as an index of enzyme activity. As
shown in Figure 3(C), phosphorylation of the Tyr416 could be
detected in lysates of PMN aggregates induced by soluble E-
selectin. This process was completely prevented by PP1, but not
by the inactive analogue PP3. Likewise, PMN adhesion to CHO-
E, but not to wild-type CHO cells, resulted in tyrosine phos-
phorylation of P110 (results not shown). Therefore, we tested the
effects of Src-family kinase inhibitors on PMN/CHO-E mixed-
cell conjugate formation. As was the case with β2 integrin block-
ade, pretreatment of PMN with PP1 slightly reduced the form-
ation of PMN/CHO-E conjugates. However, when the aggregates
were allowed to form and then treated with EGTA to reverse the
E-selectin-mediated binding, PP1, but not PP3, dose-dependently
reduced the formation of mixed conjugates (Figure 4A).
Moreover, PP1 completely prevented P110 phosphorylation in
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Figure 2 E-selectin–IgG chimaera triggers P110 tyrosine phosphorylation
and β2-integrin-dependent PMN homotypic adhesion
(A) Upper panel: PMN were incubated in standard conditions with increasing concentrations of
E-selectin–IgG chimaera for 3 min. The interaction was stopped by 1 vol. of 2 % (w/v) PFA and
single, non-aggregated PMN were counted by optical microscopy in a Burker chamber. Values
(means +− S.E.M., n = 5) indicate the percentage of aggregated PMN with respect to the total
PMN. Lower panel: alternatively, the reaction was stopped at 3 min with reducing Laemmli’s
sample buffer; samples were subjected to SDS/PAGE (7.5–12.5 % gradient gels) and probed
with anti-phosphotyrosine antibody RC20. The arrow indicates tyrosine phosphorylation of the
110 kDa proteins. Samples are from a representative of three different experiments. (B) Upper
panel: PMN, pre-incubated with or without IB4, were challenged with 20 µg/ml E-selectin–IgG
chimaera for 3 min in standard conditions. After addition of 1 vol. of 2 % (w/v) PFA, single PMN
were counted as in (A). Values (means +− S.E.M., n = 4) indicate the percentage of aggregated
PMN. Lower panel: Alternatively the reaction was stopped at 3 min, with reducing Laemmli’s
sample buffer, and samples were analysed by Western blot with anti-phosphotyrosine antibody
RC20. The Figure shows tyrosine phosphorylation of the 110 kDa protein, indicated by an arrow,
in samples from a representative of two different experiments.
PMN/CHO-E mixed-cell aggregates, whereas the inactive
analogue PP3 had no effect (Figure 4B). PP2, another inhibitor
of Src-family kinase activity, also prevented the formation of
PMN/CHO-E conjugates as well as P110 phosphorylation (results
not shown).
Although the adhesion model in mixed-cell suspensions is
necessary in order to investigate rapid and transient intracellular
events such as protein tyrosine phosphorylation, this model does
not enable monitoring of the adhesion process in real time. There-
fore we used an adhesion assay under flow conditions to investi-
gate further the effect of specific inhibitors of Src family members
on β2-integrin-mediated firm adhesion of PMN to adherent CHO-
E. We found that the majority of PMN recruited to a CHO-E mono-
layer at shear stress of 4 dyn/cm2 stopped immediately and
became firmly adhered [86 +− 10 PMN/field (mean +− S.E.M.,
n = 4)]. Only a few cells arrested after a short rolling movement.
Less than 10% of firmly adhered PMN formed homotypic
aggregates. PMN did not interact with un-transfected CHO cells.
Treatment of the CHO-E monolayer with the anti-(E-selectin)
antibody H18/7 abolished PMN recruitment [3 +− 1 PMN/field
(n = 4)]. The β2 integrin function-blocking mAb IB4 slightly
reduced the total number of PMN recruited, to 47 +− 24 PMN/field.
However, IB4 substantially reduced the number of arrested PMN,
defined as those PMN that moved less than one cell diameter
Figure 3 Src kinase activity is necessary for β2-integrin-mediated PMN
homotypic adhesion triggered by E-selectin–IgG chimaera and for P110
tyrosine phosphorylation in cell suspensions
PMN were pretreated with DMSO, different concentrations of PP1 or with 20 µM of the inactive
analogue PP3 for 1 min at room temperature. (A) PMN were stirred at for 3 min at 37◦C
and 1000 rev./min with 20 µg/ml E-selectin–IgG chimaera. The interaction was stopped by
1 vol. of 2 % (w/v) PFA, and PMN remaining single (non-aggregated) were counted by optical
microscopy in a Burker chamber. Values are means, n = 2, and indicate the percentage of
aggregated PMN with respect to the total PMN. (B) Alternatively, the reaction was stopped at
3 min with reducing Laemmli’s sample buffer; aliquots of 100 µl, corresponding to 1.25 × 106
PMN total lysate, were analysed by SDS/PAGE (7.5–12.5 % gradient gels) and probed with
anti-phosphotyrosine antibody RC20. The Figure shows tyrosine phosphorylation of the 110 kDa
proteins in samples from a representative of two different experiments. (C) PMN lysates,
corresponding to 1.25 × 106 PMN total lysate per lane, were subjected to SDS/PAGE (7.5 %
gels) and probed with anti-[phospho-Src-family (Tyr416)] antibody. The Figure shows Western
blot of samples from a representative of two experiments.
in 20 s, from 84 +− 14 to 18 +− 9 PMN/field (n = 4). Like β2
integrin blockade, treatment of PMN with PP2 dose-dependently
reduced firm adhesion and increased the fraction of rolling cells; in
contrast, the inactive control analogue PP3 did not reduce adhesive
interactions (Figure 4C). This finding confirms that β2-integrin-
dependent adhesion of PMN tethered to E-selectin requires Src-
family kinase activity.
Genetic deficiency of Hck, Fgr and Lyn impairs β2-integrin-
mediated PMN adhesion to CHO-E
To confirm the specificity of the inhibitory effects of PP1 and
PP2, we investigated the ability of PMN from hck−/−fgr−/−
and hck−/−fgr−/−lyn−/− mutant mice to form mixed conjugates
with CHO-E in mixed-cell suspensions subjected to high-shear
rotatory motion. As shown in Figure 5(A), when stirred with wild-
type bone-marrow-derived PMN for 2 min, 60 +− 11% (mean +−
S.E.M., n = 6) of CHO-E bound PMN. Mixed-cell conju-
gates were prevented by the inclusion of 5 mM EGTA; under
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Figure 4 Src kinase activity is necessary for β2-integrin-mediated PMN
adhesion to CHO-E, for P110 tyrosine phosphorylation in mixed-cell
suspensions and for PMN firm adhesion to adherent CHO-E in flow
PMN were pretreated with DMSO, different concentrations of PP1 or PP2, or with 20 µM of the
inactive analogue PP3 for 1 min at room temperature. (A) HE-loaded PMN were incubated with
BCECF-loaded CHO-E at 37◦C and 1000 rev./min stirring. After 2 min, cells were fixed
with 1 vol. of 2 % (w/v) PFA (standard condition) or alternatively, 5 mM EGTA was added to mixed
cells 30 s before addition of 2 % (w/v) PFA (stop EGTA). Samples were then processed for FACS
analysis of mixed-cell conjugates. The percentages of CHO cells binding PMN [CHO (+)] are
shown. Values are means +− S.E.M. for three to five experiments. Differences between groups
were analysed by repeated measurement ANOVA. *P < 0.05 compared with DMSO-treated
group. (B) PMN were incubated with CHO-E at 37◦C and 1000 rev./min stirring. After 2 min,
cells were lysed by 1 vol. of reducing Laemmli’s sample buffer; samples were subjected to
SDS/PAGE (7.5–12.5 % gradient gels) and probed with anti-phosphotyrosine antibody RC20.
The Figure shows tyrosine phosphorylation of P110 proteins in samples from a representative
of three different experiments. (C) PMN [(5 × 106)/ml], suspended in M199 medium containing
0.1 % (w/v) BSA, and pre-incubated with PP2, PP3 or DMSO for 5 min, were perfused at
a flow rate of 4 dyn/cm2 for 2 min. The flow was then stepped up to 10 dyn/cm2 and the
chamber was perfused with fresh medium for an additional 2 min. The interaction of PMN with
CHO cells was observed on a phase contrast video microscope with a ×20 objective. Images
were continuously recorded by a video camera. The fractions of rolling and firmly adhered
PMN were quantified over the last 20 s of flow. Cells were considered firmly adhered when
stationary for 20 s. The values (means +− S.E.M., n = 4) are the percentages of firmly adhered
and rolling PMN relative to the total number of cells recruited. Differences between groups
were analysed by repeated measurement ANOVA. *P < 0.05 compared with DMSO-treated
group.
Figure 5 Impaired adhesion to CHO-E of PMN from double hck−/−fgr−/− or
triple hck−/−fgr−/−lyn−/− mutant mice in stirred cell suspensions
(A) HE-loaded PMN from C57BL6 wild-type mice were pre-incubated for 10 min at 4◦C with or
without saturating concentrations of the anti-(β2 integrin) mAb, Game-46, or with PP2 (5 µM),
and mixed at 37◦C and 1000 rev./min stirring with BCECF-loaded CHO-E, for 2 min. The
interaction was stopped by addition of 1 vol. of 2 % (w/v) PFA (standard condition). Alternatively,
in order to disrupt the Ca2+-dependent selectin–ligand interaction, 5 mM EGTA was added to
mixed cells 30 s before the addition of 2 % (w/v) PFA (stop EGTA). Samples were then processed
for FACS analysis of mixed-cell conjugates. The percentages of CHO-E binding PMN [CHO-E
(+)] are shown. Values are means +− S.E.M. for three to six experiments. HE-loaded PMN from
wild-type or from double hck−/−fgr−/− or triple hck−/−fgr−/− lyn−/− mice were stirred for
2 min at 37◦C and 1000 rev./min with BCECF-loaded CHO-E. The interaction was stopped by
the addition of 1 vol. of 2 % PFA (standard condition). Alternatively, in order to disrupt the
Ca2+-dependent selectin–ligand interaction, 5 mM EGTA were added to mixed cells 30 s before
addition of 2 % (w/v) PFA (stop EGTA). Samples were then processed for FACS analysis of mixed
cell conjugates. Experiments were performed using bone marrow PMN pooled from five mice
per experiment. Values are means +− S.E.M. for three to six different experiments. Differences
between groups were analysed by repeated measurement ANOVA. *P < 0.05 compared with
control group and **P < 0.05 compared with double knock-out.
these conditions only 5 +− 1.6% (mean +− S.E.M., n = 6) CHO-E
bound PMN. As was the case with the human counterparts
(Figure 1), treatment of mouse PMN with a function-blocking
β2-integrin mAb, Game-46, or with the Src-family kinase inhi-
bitor PP2 (5 µM) only slightly reduced the formation of PMN/
CHO-E conjugates; however, when E-selectin-mediated bonds
were reversed by the addition of EGTA 30 s before fixation
(stop EGTA), both anti-(β2-integrin) antibody and PP2 virtually
abolished mixed-cell conjugates. These findings demonstrated
that, in mouse PMN tethered by E-selectin, β2-integrin-mediated
adhesion is regulated by mechanisms strikingly similar those of
human PMN. Therefore we investigated the ability of hck−/−fgr−/−
and hck−/−fgr−/−lyn−/− PMN to form conjugates with CHO-
E in mixed-cell suspensions. As shown in Figure 5(B), the
adhesion of PMN from double hck−/−fgr−/− mutant mice to
CHO-E was significantly reduced compared with controls.
Interestingly, hck−/−fgr−/−lyn−/− mice displayed an even greater
defect, suggesting that Lyn plays an additive role with Hck/Fgr in
the regulation of β2 integrin function in our model.
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Figure 6 Activated β2 integrins are specifically clustered at the site of adhesion in heterotypic PMN/CHO-E aggregates: role of Src kinase activity
PMN, pretreated with DMSO (control) or with 10 µM PP2 for 1 min at 37◦C, were stirred with CHO-E at 37◦C and 1000 rev./min. After 3 min, KIM127 or 327C (both 10 µg/ml) were added and
cells were incubated for a further 5 min (under static conditions) and then fixed with 2 % (w/v) PFA (standard condition). Alternatively, 5 mM EGTA was added 30 s before KIM127 (stop EGTA). After
fixation, Alexa Fluor®-488-conjugated goat anti-mouse antibody revealed KIM127 and 327C localization. (A) Negative staining was performed using samples without KIM127 or 327C. F-actin was
stained using rhodamine–phalloidin and samples were processed for confocal laser scanning microscopy. Images represent confocal micrographs from the middle third of cells. Optical Z-sections
from each sample were taken with 0.3 µm Z-step from the top to the bottom of the cell. Immunofluorescence images were acquired at high confocality (pinhole = 1 Airy unit) to achieve the thinnest
optical slices. Fluorescence intensity corresponding to the binding of KIM127 or 327C was measured using the ‘Display-Profile’ option of LSM510 software. We traced one line along the diameter
of the PMN, which crossed the cell from side to side. The intensity of fluorescence was measured along this line at both the adhesion and non-adhesion sites and was expressed in arbitrary units
(from 0 to 255). Bars are means +− S.E.M. for 100–150 cells randomly chosen. (B) and (C) show a single CHO-E surrounded by adherent PMN and stained with 327C and KIM127 respectively.
(D) and (E) show a single CHO-E carrying 3 and 5 adherent PMN respectively. (F) A single CHO-E and 4 non-adherent PMN.
Src-family kinase activity is required for the formation of sites of
firm adhesion based on clustered activated β2 integrins in PMN
tethered by E-selectin
Because Src-family kinases play a central role in phagocyte
integrin signalling, the strict dependence of formation of stable
homotypic or heterotypic PMN conjugates on both β2 integrins
and Src-family kinase activity or expression (Figures 2–5) sug-
gested to us that outside-in signalling ensuing from integrin lig-
ation was required for full integrin function. In order to strengthen
this hypothesis, we investigated, by flow cytometry and confocal
microscopy, the presence and cellular distribution of activated
β2 integrins, as detected by two mAbs that recognize distinct
activation-dependent epitopes. The mAbs used were KIM127,
which recognizes epitopes in the cysteine-rich repeat region of
the β2 chain that are shielded by the α subunit in the closed–
inactive conformation and become exposed in the open–active
conformation of the integrin [30], and 327C, which recognizes an
activation-dependent epitope in the βI-like domain [17].
Using flow cytometry, we sought to determine whether E-
selectin–IgG stimulated up-regulation of these epitopes in non-
aggregated PMN. To do this, PMN were incubated under static
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conditions to prevent cell–cell contact and homotypic aggre-
gation. At baseline, 10 +− 1.5% of the total β2 integrins (defined
by staining with IB4) were in an activated state (defined by
staining with KIM127 or 327C). This value was not significantly
modified by the addition of soluble E-selectin (20 µg/ml) to the
PMN (8.3 +− 3.6%). In contrast, Mn2+, a direct inducer of integrin
conformational changes, up-regulated the KIM127 epitope to
40 +− 14% of total β2 integrins. Similar results were obtained
when 327C was used to monitor integrin activation (results not
shown). Therefore E-selectin did not stimulate detectable integrin
conformational changes.
Interestingly, both KIM127 and 327C epitopes formed clusters
specifically located at the contact sites between CHO-E cells and
PMN (Figures 6B and 6C). Activated β2 integrins could be de-
tected by KIM127 staining (although at reduced levels) in samples
fixed after brief EGTA treatment (Figure 6D), confirming that
upon disruption of E-selectin bonds, integrins could sustain PMN/
CHO-E adhesion. In contrast, both KIM127 and 327C epitopes
were absent at the adhesion sites in mixed-cell conjugates formed
by PP2-treated PMN and CHO-E (Figure 6E), indicating that
adhesion under these conditions does not involve integrins, but
is mainly due to E-selectin-mediated binding. In fact, these con-
jugates completely disaggregated after brief exposure to EGTA
before fixation (Figure 6F).
Similarly, confocal microscopic examination of E-selectin-
induced homotypic aggregates showed that KIM127 or 327C
epitopes, virtually absent at the regions of the cell membrane not
involved in adhesion, were readily detectable at sites of cell–cell
interactions (results not shown).
Pyk2 undergoes tyrosine phosphorylation in a β2-integrin- and
Src-family-kinase-dependent manner in PMN aggregated by
soluble E-selectin or adherent to CHO-E
To characterize better the Src-family-kinase-mediated signal(s)
involved in the regulation β2 integrin adhesive function, we
sought to identify components of the P110 phosphoprotein (Fig-
ures 2 and 3). We focused on the proline-rich FAK (focal adhesion
kinase) termed Pyk2, which is expressed in cells of myeloid
origin and undergoes tyrosine phosphorylation upon β2-integrin-
mediated leucocyte adhesion. To detect Pyk2 phosphorylation,
lysates from E-selectin-aggregated PMN were immunoblotted for
tyrosine phosphorylated proteins and Pky2. The results indicated
that Pyk2 could be detected in the upper part of P110 phospho-
proteins (Figure 7A). This conclusion was confirmed by immuno-
depletion experiments. Lysates from E-selectin-stimulated PMN
were subjected to immuno-depletion with an anti-Pyk2 antibody
or with goat serum as control. The remaining tyrosine phos-
phorylated proteins in the supernatants were immunoprecipi-
tated with the anti-phosphotyrosine antibody PY99. The immuno-
precipitate was then analysed for tyrosine phosphorylation and
Pyk2. Pyk2 was detected in the PY99-immunoprecipitates and mi-
grated as a clear-cut tyrosine-phosphorylated protein in the upper
part of P110; this band was no longer detectable in PY99
immunoprecipitates from Pyk2-depleted lysates (Figure 7B).
Notably, like P110, Pyk2 tyrosine phosphorylation in PMN stirred
with soluble E-selectin or with CHO-E was prevented by β2
integrin blockade, by IB4 and by the Src inhibitor PP2 (Figure 7C).
In order to demonstrate unequivocally that tyrosine phos-
phorylation of Pyk2 was mediated by Src kinases, we investigated
the ability of PMN from hck−/−fgr−/− and hck−/−fgr−/−lyn−/−
mutant mice to phosphorylate Pyk2 during adhesion to CHO-E in
mixed-cell suspensions subjected to high-shear rotatory motion.
As shown in Figure 7(D), Pyk2 tyrosine phosphorylation was
readily detectable in PMN stirred in the absence of CHO-E and
Figure 7 Pyk2 is a component of P110 and undergoes tyrosine
phosphorylation in an Src-kinase- and integrin-dependent manner
(A) Lysates from unstimulated or E-selectin-activated PMN were analysed by Western blot (w.b.)
with anti-phosphotyrosine antibody PY99. After stripping, the same samples were re-probed with
anti-Pyk2 antibody. (B) Lysates from unstimulated or E-selectin-activated PMN were subjected
to two runs of immunoprecipitation with non-immune goat antiserum (control) or with
anti-Pyk2 antibody (Pyk2-depleted) (w.b., Western blot). Tyrosine-phosphorylated proteins in the
remaining supernatants were then immunoprecipitated with PY99 anti-phosphotyrosine antibody
(Pyk2-precipitated). After stripping, the same samples were re-probed with anti-Pyk2 anti-
body. In control samples, Pyk2 can be detected in PY99 immunoprecipitates and corresponds
to a clear-cut tyrosine-phosphorylated protein in the upper region of P110. This protein is
not detectable in Pyk2-depleted PY99 immunoprecipitates. (C) PMN untreated or pretreated
with DMSO, 10 µM PP2 or 20 µg/ml IB4 were incubated under stirred conditions for 3 min
in the absence or in the presence of soluble E-selectin (E-sel) or CHO-E (5:1 PMN/CHO-E).
Pyk2 was immunoprecipitated from cell lysates, and immune complexes were first analysed
by Western blot (WB) with PY99 and then re-probed with anti-Pyk2 antibody. Bars indicate
absorbances of PY99 Western blots. The Figure shows the results from one representative of
three different experiments. (D) PMN from C57BL6 (wild-type), or from double hck−/− fgr−/−
or triple hck−/−fgr−/− lyn−/− mice, were incubated in the absence or in the presence of CHO-E
for 3 min at 37◦C with stirring at 1000 rev./min. Pyk2 was immunoprecipitated from cell lysates,
and immune complexes were first analysed by Western blot (WB) with PY99 and then re-probed
with anti-Pyk2 antibody. Bars indicate the ratios between the absorbances of PY99 and Pyk2
Western blots. Values are from one representative of two different experiments.
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increased in PMN adherent to CHO-E. In contrast, Pyk2 tyrosine
phosphorylation, either in PMN stirred alone or in the presence
of CHO-E, was strongly reduced in PMN from hck−/−fgr−/− and
virtually abolished in hck−/−fgr−/−lyn−/− mice respectively. We
conclude that Src kinases mediate Pyk2 tyrosine phosphorylation
in PMN in our model.
DISCUSSION
In the present paper we demonstrate for the first time that a
Src-dependent signal is necessary to achieve full β2 integrin
activation and to support shear-resistant firm adhesion of PMN
tethered by E-selectin. Our results using E-selectin-expressing
CHO cells and recombinant, soluble E-selectin confirm previous
data indicating that E-selectin-receptor interaction promotes β2
integrin adhesiveness [8–12]. Furthermore, under conditions of
rotatory shear motion, we were able to demonstrate the occurrence
of protein tyrosine phosphorylation and Src kinase activation
in homotypic (PMN/PMN) aggregates triggered by soluble E-
selectin or in heterotypic (PMN/CHO-E) conjugates. Both of these
events were prevented by β2 integrin blockade. In turn, the use of
pharmacological inhibitors or of PMN isolated from hck−/−fgr−/−
and hck−/−fgr−/−lyn−/− mice demonstrated that Src kinase activity
was required for firm β2-integrin-dependent PMN adhesion in the
presence of rotatory shear or laminar flow. Overall, these results
indicate that intracellular events initiated by E-selectin–receptor
interaction act in concert with a Src-mediated outside-in signal,
downstream of β2 integrins, to induce full integrin adhesiveness
and shear resistance.
Our conclusions are also supported by detection of activation-
dependent epitopes exposed in the open/extended conformation
of β2 integrins in PMN. Confocal microscopic analysis revealed
that fully active β2 integrins were specifically localized at sites
of cell–cell contact in PMN/CHO-E conjugates and in homo-
typic PMN aggregates triggered by soluble E-selectin. Our re-
sults with the two different antibodies indicated that, under our ex-
perimental conditions, in adherent PMN, conformational change
in integrin molecules involves extension of bent integrin (detected
by KIM127) and activation of I-domain (detected by 327C).
Exposure of these epitopes at the adhesion sites required Src
kinase activity, supporting the conclusion that Src kinases are re-
quired for full activation of the integrin. In contrast, flow cyto-
metric analysis of PMN exposed to soluble E-selectin under static
conditions, which impedes cell–cell contact and the formation
of aggregates, failed to demonstrate an increased expression of
these new epitopes, indicating that, under our conditions, con-
formational changes detected by the antibodies follow integrin–
ligand binding.
To determine the nature of the Src-dependent signal, we
identified that Pyk2 becomes specifically phosphorylated in a
Src- and β2-integrin-dependent manner in E-selectin-induced
homotypic PMN/PMN aggregates or in heterotypic PMN/CHO-
E conjugates. Pyk2 becomes activated upon stimulation of β2-
integrins in leucocytes and may couple integrins to other sig-
nalling molecules and the cytoskeleton [31–35]. Moreover, a
cross-talk between members of the Src-family kinases and Pyk2
plays an important role in the regulation of migration in macro-
phages [36–38]. In our model, Pyk2 is activated downstream of
β2 integrins in a Src-family-kinase-dependent manner, strongly
suggesting that it may be involved in the regulation of integrin
function in PMN tethered by selectins. However, the presence
of other components of P110 is indicated by PY99 immuno-
detection in Pyk2-depleted immunoprecipitates. Experiments
attempting to identify the other component(s) of P110 have
excluded FAK, phospholipase Cγ or Cbl (results not shown).
Clearly, further investigation into the role of Pyk2 and the nature
of the other components of the P110 band is needed.
The nature of the signal, as well as the changes of β2 integrins
initially generated by E-selectin in our models remain to be
determined. However, several other groups have reported that
E-selectin may trigger β2 integrin adhesiveness through a p38
MAPK (mitogen-activated protein kinase) pathway. For example,
Simon et al. [11] showed that p38 MAPK inhibitors block β2
integrin function initiated by E-selectin under conditions of flow.
In agreement with these observations, Kumar et al. [39] found that
E-selectin induced chemotaxis and p38 MAPK phosphorylation
in human monocytes. Moreover, Green et al. [12] extended
these observations to show that inhibition of p38 and p42/44
MAPKs blocked clustering of high-affinity β2 integrin upon co-
capping of L-selectin and PSGL-1 driven by E-selectin. Past
observations pointed to signals triggered by E-selectin. None
of these studies, however, investigated the contribution of β2
integrins in the signalling events. The present results strongly
support the conclusion that Src kinase activity in PMN tethered
by E-selectin is mainly a consequence of β2 integrin engagement.
However, the possibility that Src kinases are also involved in
the initial E-selectin–receptor signalling cannot be completely
excluded. Structural and functional studies of β2 integrins support
the concept that these receptors may exist not only in a closed/bent
state or an open/extended high-affinity state, but also in an inter-
mediate conformation that is not able to bind soluble ligands but
may sustain lower affinity cell adhesion to immobilized ligands
[40,41]. More recently, this concept has been further supported
by Shamri et al. [42]. These authors demonstrated that LFA-
1 (lymphocyte function-associated antigen 1)-mediated arrest of
lymphocytes on ICAM-1 follows a double-step model involving
a first instantaneous extension of bent LFA-1, induced by bound
chemokines, and a final activation process that is mediated by
the ligand. In studies focused on integrin activation by selectins,
Ma et al. [14] and Green et al. [12] demonstrated that P-selectin
binding to PSGL-1, or E-selectin binding to both L-selectin and
PSGL-1, initiates β2 integrin function as a result of an increased
avidity due to β2 integrin micro-clustering on the PMN surface.
Overall, the present results are in agreement with a model in
which E-selectin binding to leucocyte receptor(s) results in an
‘intermediate’ activation state of the integrin, which then trans-
lates into a fully active state as a consequence of both ligand
binding and activation of Src-signalling pathways.
This process is necessary for shear-resistant β2-integrin-medi-
ated adhesion of PMN tethered by E-selectin under physiological
flow. This new role for Src kinases, which are important regulators
of leucocyte inflammatory function [43–45], supports the con-
tention that these signalling molecules may prove to be useful
targets for anti-inflammatory pharmacological interventions.
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